These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1434 related items for PubMed ID: 16613299

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Local recurrence rates in breast cancer patients treated with intraoperative electron-boost radiotherapy versus postoperative external-beam electron-boost irradiation. A sequential intervention study.
    Reitsamer R, Peintinger F, Kopp M, Menzel C, Kogelnik HD, Sedlmayer F.
    Strahlenther Onkol; 2004 Jan; 180(1):38-44. PubMed ID: 14704843
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Controversies in breast conservation treatment for breast cancer].
    Motomura K, Egawa C, Komoike Y, Inaji H, Koyama H.
    Gan To Kagaku Ryoho; 2004 Feb; 31(2):168-75. PubMed ID: 14997746
    [Abstract] [Full Text] [Related]

  • 11. Patients with breast cancer and positive sentinel nodes: axillary dissection or axillary radiotherapy?
    Zippel D, Papa M.
    Arch Surg; 2003 Oct; 138(10):1159. PubMed ID: 14557139
    [No Abstract] [Full Text] [Related]

  • 12. Sentinel lymph node biopsy for breast cancer: indications, contraindications, and new directions.
    Cody HS.
    J Surg Oncol; 2007 May 01; 95(6):440-2. PubMed ID: 17458860
    [No Abstract] [Full Text] [Related]

  • 13. Should all patients undergoing breast conserving therapy for DCIS receive radiation therapy? Yes. Radiation therapy, an important component of breast conserving treatment for patients with ductal carcinoma in situ of the breast.
    Buchholz TA, Haffty BG, Harris JR.
    J Surg Oncol; 2007 Jun 15; 95(8):610-3. PubMed ID: 17221862
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Radiation therapy for intraductal carcinoma. Is it an equal alternative?
    Silverstein MJ, Waisman JR, Gierson ED, Colburn W, Gamagami P, Lewinsky BS.
    Arch Surg; 1991 Apr 15; 126(4):424-8. PubMed ID: 1848972
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Blood hemoglobin level and treatment outcome of early breast cancer.
    Henke M, Sindlinger F, Ikenberg H, Gerds T, Schumacher M.
    Strahlenther Onkol; 2004 Jan 15; 180(1):45-51. PubMed ID: 14704844
    [Abstract] [Full Text] [Related]

  • 20. Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS?
    Cox CE, Nguyen K, Gray RJ, Salud C, Ku NN, Dupont E, Hutson L, Peltz E, Whitehead G, Reintgen D, Cantor A.
    Am Surg; 2001 Jun 15; 67(6):513-9; discussion 519-21. PubMed ID: 11409797
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 72.